Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Outcomes of IDH1 - and IDH2 -Mutated AML Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Evan C. Chen, MD, Shuli Li, PhD, Ann-Kathrin Eisfeld, MD, Marlise R Luskin, MDMS, Alice S. Mims, MD, Daniel Jones, MD PhD, Joseph H. Antin, MD, Corey Cutler, MD MPH, FRCPC, John Koreth, MBBS, DPhil, Vincent T. Ho, MD, Mahasweta Gooptu, MD, Rizwan Romee, MD, Areej El-Jawahri, MD, Steven L. McAfee, MD, Zachariah Defilipp, MD, Robert J. Soiffer, MD, Yi-Bin Chen, MD, Amir T. Fathi

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-140353

Published: 2020

Journal Articles

Treatment of Acquired Hemophilia a with Rituximab and Emicizumab

Evan C. Chen, MD, William J. Gibson, MD PhD, Paula Temoczko, NP, Nathan T. Connell, MDMPH, Robert Handin, MD, Aric D. Parnes, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-137262

Published: 2020

Journal Articles

Clinical Outcomes Following Frontline Chemotherapy for Patients with Myeloid Malignancies Harboring Splicing Factor Mutations

Evan C. Chen, MD, Gabriela S. Hobbs, MD, Philip C. Amrein, MD, Timothy A. Graubert, MD, Amir T. Fathi, MD, Andrew M. Brunner, MD

Blood (2018) 132 (Supplement 1): 4364.

https://doi.org/10.1182/blood-2018-99-111982

Published: 2018

Journal Articles

Increased Incidence of Philadelphia Negative B-Cell Acute Lymphoblastic Leukemia Among Adults of Hispanic Ethnicity: A Population Based Study

Ashley M. Perry, BS, Evan C. Chen, MD, Marla M. Jalbut, MD, Lillian Werner, MS, Gabriela S. Hobbs, MD, Philip C. Amrein, MD, Amir T. Fathi, MD MD BS, Andrew M. Brunner, MD

Blood (2017) 130 (Supplement 1): 2570.

https://doi.org/10.1182/blood.V130.Suppl_1.2570.2570

Published: 2017

Journal Articles

The Impact of Antimicrobial Prophylaxis during Induction Chemotherapy for Acute Myeloid Leukemia in the Current Era

Marla M. Jalbut, MD, Evan C. Chen, MD, Gabriela S. Hobbs, MD, Ashley M. Perry, BS, Lillian Werner, MS, Philip C. Amrein, MD, Amir T. Fathi, MD MD BS, Andrew M. Brunner, MD

Blood (2017) 130 (Supplement 1): 2586.

https://doi.org/10.1182/blood.V130.Suppl_1.2586.2586

Published: 2017

Journal Articles

Autoimmune Hemolytic Anemia Confers Risk of Thromboembolism That Is Not Attributable to Usual Thrombosis Risk Factors: A Longitudinal, Retrospective Cohort Study Using the "Stride" Database

Evan C. Chen, MD, Pooja D. Loftus, Susan C. Weber, PhD, Nhat Minh Hoang, James Gilbert, MD, Shivaani Kummar, MD

Blood (2016) 128 (22): 1258.

https://doi.org/10.1182/blood.V128.22.1258.1258

Published: 2016

NARROW

Outcomes of IDH1 - and IDH2 -Mutated AML Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Treatment of Acquired Hemophilia a with Rituximab and Emicizumab

Clinical Outcomes Following Frontline Chemotherapy for Patients with Myeloid Malignancies Harboring Splicing Factor Mutations

Increased Incidence of Philadelphia Negative B-Cell Acute Lymphoblastic Leukemia Among Adults of Hispanic Ethnicity: A Population Based Study

The Impact of Antimicrobial Prophylaxis during Induction Chemotherapy for Acute Myeloid Leukemia in the Current Era

Autoimmune Hemolytic Anemia Confers Risk of Thromboembolism That Is Not Attributable to Usual Thrombosis Risk Factors: A Longitudinal, Retrospective Cohort Study Using the "Stride" Database

Email alerts

ASH Publications

American Society of Hematology

Outcomes of IDH1 - and IDH2 -Mutated AML Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Treatment of Acquired Hemophilia a with Rituximab and Emicizumab

Clinical Outcomes Following Frontline Chemotherapy for Patients with Myeloid Malignancies Harboring Splicing Factor Mutations

Increased Incidence of Philadelphia Negative B-Cell Acute Lymphoblastic Leukemia Among Adults of Hispanic Ethnicity: A Population Based Study

The Impact of Antimicrobial Prophylaxis during Induction Chemotherapy for Acute Myeloid Leukemia in the Current Era

Autoimmune Hemolytic Anemia Confers Risk of Thromboembolism That Is Not Attributable to Usual Thrombosis Risk Factors: A Longitudinal, Retrospective Cohort Study Using the "Stride" Database

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only